A Korean SME seeks distributors for a wearable device for chronic migraine treatment
Published by Enterprise Europe Network
created
Deadline: May 25, 2024
Received 0 expressions of interest

Summary

The company conducts both animal studies and clinical trials in partnership with renowned university-hospitals in Korea. A wearable prophylactic and acute treatment device for chronic migraine is manufactured in a MDSAP approved manufacturing facility in Korea. The company seeks distributors for the EU region.

Description

The device has two protocols of treatment: preventive and acute protocols, like the typical method of treatment for chronic migraine. By wearing the device for 30 minutes, the device transcutaneous delivers electric current on trigeminal nerve fibers and modulates the autonomic nervous system. All typical types of migraine patients can use the device. It shortens migraine duration, reduces the number of migraine attack, and weakens attack intensity. It is a medical device in Korea, the US, Europe, and Canada. As approved in the EU region, distribution and sales are needed.

Related Keywords

Start a discussion with the space members

Submit


Cookies help us provide, protect and improve NIR-VANA’s services.

Cookies on this website are used to personalize content, provide social media features, and analyze traffic.

In addition, we share information about your use of the website with web analytics partners, who may combine it with other information that you have provided to them or that they have collected from your use of their services.

If you want to know more, you can explore our product below or visit our Cookie Policy.

Cookie settings

Required

Necessary cookies help make a web page usable by activating basic functions such as page navigation and access to secure areas of the web page. The website cannot function properly without these cookies.

Statistics

Statistical cookies help web page owners understand how visitors interact with web pages by gathering and information anonymously.